Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Evaluation of Muscle Performance and Cardiopulmonary Fitness in Patients with Multiple SclerosisImplications for Rehabilitation.
Chronic cerebrospinal venous insufficiency and multiple sclerosis: a comprehensive meta-analysis of case-control studies.
The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage.
Modulation of kallikrein-kinin system by the angiotensin-converting enzyme inhibitor alleviates experimental autoimmune encephalomyelitis.
The Role of Microglia and Matrix Metalloproteinases Involvement in Neuroinflammation and Gliomas.
Monoclonal antibodies as disease modifying therapy in multiple sclerosis.
Cause and prevention of demyelination in a model multiple sclerosis lesion.
Pharmacogenomics strategies to optimize treatments for multiple sclerosis: Insights from clinical research.
A pilot randomized trial of progressive resistance exercise augmented by neuromuscular electrical stimulation for people with Multiple Sclerosis who use walking aids.
Anti-Inflammatory Potential of Newly Synthesized 4-[(Butylsulfinyl)methyl]-1,2-benzenediol in Lipopolysaccharide-Stimulated BV2 Microglia.
Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine.
Gain of Olig2 function in oligodendrocyte progenitors promotes remyelination.
Resilience Predicts Functional Outcomes in People Aging with Disability: A Longitudinal Investigation.
Chronic Pain in Multiple Sclerosis Patients: Utility of Sensory Quantitative Testing in Patients with Fibromyalgia Comorbidity.
Heterogeneous Network Edge Prediction: A Data Integration Approach to Prioritize Disease-Associated Genes.
AQP4 autoantibody assay performance in clinical laboratory service.
TRANSGLUTAMINASE 2 IS INVOLVED IN HOMOCYSTEINE-INDUCED ACTIVATION OF HUMAN THP-1 MONOCYTES.
Diagnosis and quantification of cognitive fatigue in multiple sclerosis.
Exosomes as nanocarriers for immunotherapy of cancer and inflammatory diseases.
Extending Treatment Up To Eight Weeks With Infusion Medication Shown Safe and Effective in Patients with Multiple Sclerosis
Regulatory B cells in human inflammatory and autoimmune diseases: from mouse models to clinical research.
Human adipose-derived mesenchymal stem cells engineered to secrete IL-10 inhibit APC function and limit CNS autoimmunity.
Lung volume recruitment in multiple sclerosis.
Neuropharmacological Actions of Metformin in Stroke.
What is new in MS spasticity research? Poster session highlights.
Pages
« first
‹ previous
…
543
544
545
546
547
548
549
550
551
…
next ›
last »